help button home button ClinMed NetPrints
HOME HELP FEEDBACK BROWSE ARTICLES BROWSE BY AUTHOR
Warning: This article has not yet been accepted for publication by a peer reviewed journal. It is presented here mainly for the benefit of fellow researchers. Casual readers should not act on its findings, and journalists should be wary of reporting them.

This Article
Right arrow Full Text
Services
Right arrow Similar articles in this netprints
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ozeren, M.
Right arrow Articles by Yucel, E.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Ozeren, M.
Right arrow Articles by Yucel, E.
Related Collections
Right arrow Cardiovascular Medicine:
Other Cardiovascular Medicine

clinmed/2004110001v1 (February 28, 2005)
Contact author(s) for copyright information

USAGE OF ILOPROST IN VASCULO-BEHCET'S DISEASE Case Report and Literature Review

Murat Ozeren, Pelin Durmazlar, and Ertan Yucel

Background: Vasculo-Behcet's disease is a rare but serious form of the disease and carries a poor prognosis. Here we are presenting first time successful results of iloprost in a VBD to prevent the patient from the catastrophic results of surgery. Patient and method: A 34 year old male patient with arterial involvement due to Vasculo-Behcet's disease was hospitalized. Iloprost treatment was planned to the patient because of his previous vascular operations and high recurrence rate of surgery in Behcet?s disease. Conclusion: Iloprost is a safe and promising drug for the treatment of Vasculo-Behcet's disease with arterial involvement and also we are recommending that iloprost can be used as an alternative first line medical treatment.




HOME HELP FEEDBACK BROWSE ARTICLES BROWSE BY AUTHOR